Navigation Links
West Announces Third Quarter 2009 Results
Date:11/3/2009

the results and business expectations at 9:00 a.m. Eastern Standard Time today. To participate on the call, please dial 210-839-8398 or 888-790-3758. The passcode is WST.

A live broadcast of the conference call will be available through the Company's web site, www.westpharma.com, in the "Investor" section. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. An online archive of the broadcast will be available at the site two hours after the live call and will be available through Tuesday, November 17, 2009, by dialing 866-346-1326 or 203-369-0000 and entering conference ID# 4311.

Exubera® is a registered trademark of Pfizer, Inc.

                           WEST PHARMACEUTICAL SERVICES, INC.
                           CONSOLIDATED STATEMENTS OF INCOME
                                      (UNAUDITED)
                          (in millions, except per share data)

                          Three Months Ended             Nine Months Ended
                             September 30,                 September 30,
                             -------------                 -------------
                          2009            2008         2009          2008
                          ----            ----         ----          ----
    Net sales        $258.9   100%   $256.2  100% $762.3  100%  $806.3   100%
    Cost of goods
     and services
     sold             187.2    72     190.2   74   542.6   71    573.3    71
                      -----    --     -----   --   -----   --    -----    --
      Gross profit     71.7    28      66.0   26   219.7   29    233.0    29
    Research and
     development        5.1     2       4.6    2    14.1    2     14.8     2
    Selling,
     general and
    administrative
     expenses          44.3    17      41.5   16   132.3   17    122.5    15
    Restructuring
     and other
     items           
'/>"/>
SOURCE West Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... July 2, 2015  Before you head outdoors with your ... can stay safe and healthy. Take steps to protect yourself ... http://nyackhospital.org/summersafety Protect Your Skin From the Sun ... can increase your risk of skin cancer. To protect your ... as possible, especially during midday hours. Wear a hat with ...
(Date:7/2/2015)... June 26, 2015 Research and ... "Vitamin D Market by Analog, Application, End-User & by Region ... their offering. This market is projected to reach ... D in different applications and rising opportunities in countries such ... , Italy , and Brazil ...
(Date:7/2/2015)... July 2, 2015 Numotion,s Board of Directors ... that Tamas Feitel has joined the Company ... after a highly successful 18 year career at GE ... strategy, profitability, and productivity to result in significant industry ... was Chief Financial Officer for GE Healthcare Global Services, ...
Breaking Medicine Technology:First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2
... (Nasdaq: TRBN ) today announced financial results for ... 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , Third ... , Revenue for the third quarter and nine months ... million, respectively, compared with $3.8 million and $12.2 million, ...
... , , SADDLE RIVER, N.J., Nov. ... provider of sales and marketing support to U.S. pharmaceutical companies, ... ended September 30, 2009. , Commenting on today,s announcement, ... quarter 2009 revenues of $21.0 million were lower than last ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 2Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 3Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 4Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 5Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 6Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 7PDI Reports 2009 Third Quarter Financial Results 2PDI Reports 2009 Third Quarter Financial Results 3PDI Reports 2009 Third Quarter Financial Results 4PDI Reports 2009 Third Quarter Financial Results 5PDI Reports 2009 Third Quarter Financial Results 6PDI Reports 2009 Third Quarter Financial Results 7PDI Reports 2009 Third Quarter Financial Results 8PDI Reports 2009 Third Quarter Financial Results 9PDI Reports 2009 Third Quarter Financial Results 10PDI Reports 2009 Third Quarter Financial Results 11
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar Association ... 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law ... of investigating these types of cases. , Each year, New York State residents ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Talcum powder ... to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous ... powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. The ...
(Date:7/3/2015)... ... 03, 2015 , ... First Choice Emergency Room , the largest network ... as the new Medical Director of its Frisco facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:7/3/2015)... Texas (PRWEB) , ... July 03, 2015 , ... Yisrayl ... a new article this week that he says will reveal biblical truth and expose ... titled “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the core ...
Breaking Medicine News(10 mins):Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... funding to PBTF Institute at Duke accelerates search for ... ... The Pediatric Brain,Tumor Foundation (PBTF) is giving an additional $6 million ... to $12 million., To view the Multimedia News Release, go ...
... masses 2 to 3 times faster, dramatically boosting survival ... report they have dramatically increased the survival rate for ... by fine-tuning the dosage and timing for administering the ... from what,s usually an 80 percent death rate in ...
... No benefit seen for prehypertensive people in morning use, ... A daily aspirin can control prehypertension, but only if ... , An aspirin taken every morning didn,t lower the ... did, Dr. Ramon C. Hermida reported Wednesday at the ...
... hits five cities in one ... ... primary,teacher of the Institute for Integrative Nutrition, the world,s largest,nutrition school, is ... June 14. He will demystify the confusion people,experience from all the different ...
... (NYSE:,AZN) today announced that the U.S. Food and ... for the maintenance,treatment of patients with bipolar I ... is approved by the FDA for the treatment ... approved by the FDA for,the treatment of both ...
... tea consumption may,promote cancer-preventive effects in people at risk ... some kinds of cancer, according to a,study in the ... on newsstands now., In a study to establish ... colon cancers, 6 cancerous and 6 non-cancerous,adjacent human gastric ...
Cached Medicine News:Health News:Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke 2Health News:Clot-Busting Treatment Improves Bleeding Stroke Outcomes 2Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:Institute for Integrative Nutrition Begins Road Tour 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9Health News:Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer 2
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
...
Pre-set guard for precise depth incision, bi-directional blade can cut left or right. 250 micron....
Universal, clear, lightweight plastic with smooth edges & ventilation holes for patient comfort...
Medicine Products: